Drug recall · January 16, 2019
Cidofovir Injection 375mg/5mL recall
Why: Lack of Assurance of Sterility: complaints received about dried powder on the outside of bottle
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Cidofovir Injection 375mg/5mL (75mg/mL) vial injection. 5 mL vials, Rx only, Mfd by: Emcure Pharmaceuticals Ltd., Hinjawadi, Pune, India Mfg. for : Heritage Pharmaceuticals Inc. NDC 23155-0216-31
- Lots / codes
Lot #: VCIA082, Exp. MAY 2020; VCIA083, VCIA084, Exp. JUNE 2020
- Quantity
- 5,060 units
- Company
- Heritage Pharmaceuticals, Inc., East Brunswick, NJ
- Distribution
- Nationwide
- Initiated
- January 2, 2019 · Voluntary: Firm initiated
- Classified
- January 8, 2019
- Reported
- January 16, 2019
- Ended
- February 19, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cidofovir
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.